Application of radiosensitizers in cancer radiotherapy

L Gong, Y Zhang, C Liu, M Zhang… - International journal of …, 2021 - Taylor & Francis
Radiotherapy (RT) is a cancer treatment that uses high doses of radiation to kill cancer cells
and shrink tumors. Although great success has been achieved on radiotherapy, there is still …

[HTML][HTML] Engineering interferons and interleukins for cancer immunotherapy

PG Holder, SA Lim, CS Huang, P Sharma… - Advanced drug delivery …, 2022 - Elsevier
Cytokines are a class of potent immunoregulatory proteins that are secreted in response to
various stimuli and act locally to regulate many aspects of human physiology and disease …

Radiation-induced tumor immune microenvironments and potential targets for combination therapy

S Guo, Y Yao, Y Tang, Z Xin, D Wu, C Ni… - … and Targeted Therapy, 2023 - nature.com
As one of the four major means of cancer treatment including surgery, radiotherapy (RT),
chemotherapy, immunotherapy, RT can be applied to various cancers as both a radical …

[HTML][HTML] Immunotherapy in soft tissue and bone sarcoma: unraveling the barriers to effectiveness

M Panagi, P Pilavaki, A Constantinidou… - Theranostics, 2022 - ncbi.nlm.nih.gov
Sarcomas are uncommon malignancies of mesenchymal origin that can arise throughout the
human lifespan, at any part of the body. Surgery remains the optimal treatment modality …

Lattice or oxygen-guided radiotherapy: what if they converge? Possible future directions in the era of immunotherapy

G Ferini, V Valenti, A Tripoli, SI Illari, L Molino, S Parisi… - Cancers, 2021 - mdpi.com
Simple Summary Oxygen-guided radiotherapy is a new modality for cancer irradiation.
Spatially Fractionated Radiation Therapy allows the treatment of hypoxic tumor areas with …

[HTML][HTML] Combination of radiation therapy, bempegaldesleukin, and checkpoint blockade eradicates advanced solid tumors and metastases in mice

AA Pieper, AL Rakhmilevich… - … for ImmunoTherapy of …, 2021 - ncbi.nlm.nih.gov
Background Current clinical trials are using radiation therapy (RT) to enhance an antitumor
response elicited by high-dose interleukin (IL)-2 therapy or immune checkpoint blockade …

Novel engineered IL-2 Nemvaleukin alfa combined with PD1 checkpoint blockade enhances the systemic anti-tumor responses of radiation therapy

K He, N Puebla-Osorio, HB Barsoumian… - Journal of Experimental …, 2024 - Springer
Abstract Background Combining interleukin-2 (IL-2) with radiotherapy (RT) and immune
checkpoint blockade (ICB) has emerged as a promising approach to address ICB …

[HTML][HTML] Combining bempegaldesleukin (CD122-preferential IL-2 pathway agonist) and NKTR-262 (TLR7/8 agonist) improves systemic antitumor CD8+ T cell …

AS Rolig, DC Rose, GH McGee, W Rubas… - … for Immunotherapy of …, 2022 - ncbi.nlm.nih.gov
Background Tumor cell death caused by radiation therapy (RT) triggers antitumor immunity
in part because dying cells release adjuvant factors that amplify and sustain dendritic cell …

[HTML][HTML] Combination of vasculature targeting, hypofractionated radiotherapy, and immune checkpoint inhibitor elicits potent antitumor immune response and blocks …

S Pierini, A Mishra, R Perales-Linares… - … for immunotherapy of …, 2021 - ncbi.nlm.nih.gov
Background Tumor endothelial marker 1 (TEM1) is a protein expressed in the tumor-
associated endothelium and/or stroma of various types of cancer. We previously …

Infiltrating T lymphocytes in the tumor microenvironment of small cell lung cancer: a state of knowledge review

Y Chen, Y Jin, X Hu, M Chen - Journal of Cancer Research and Clinical …, 2022 - Springer
Immune checkpoint inhibitors (ICIs) have brought new hope for the treatment of patients with
small cell lung cancer (SCLC) over the past decades. However, the overall response rate is …